Consumption of mushrooms reduces prostate cancer risk: Study

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system's coordinators, helping other immune cells fight longer and harder.

The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines.

A high-fat diet does more than overload the liver with fat. New research from MIT shows that prolonged exposure to fatty foods can push liver cells into a survival mode that quietly raises the risk of cancer.

UBC Okanagan researchers have uncovered how plants create mitraphylline, a rare natural compound linked to anti-cancer effects.

A new study led by researchers at University College London (UCL) shows that chronic exposure to toxic air can significantly diminish the health benefits of regular physical activity.

Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumours survive stress.

Researchers at the UCLA Health Jonsson Comprehensive Cancer Centre have identified a single protein, IGF2BP3, that links these two processes together in leukaemia cells. The protein alters how cells break down sugar, favouring a fast but inefficient energy pathway, while also modifying RNA that helps produce the proteins leukaemia cells need to survive and multiply.

The Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease linked to obesity and type 2 diabetes that can lead to cirrhosis, liver failure, and even liver cancer.

A team of researchers at Lund University in Sweden has identified the molecular tools that are needed to reprogram ordinary cells into specialised immune cells.

The results show that childhood cancer survivors had a lower risk of contracting COVID 19, but were 58 per cent more likely to develop severe disease if they did become infected.